Wall Street Analysts Think Syndax (SNDX) Could Surge 50.26%: Read This Before Placing a Bet

Syndax Pharmaceuticals (SNDX) closed the last trading session at $23.50, gaining 18.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 35.31 indicates a 50.3% upside potential. The average comprises 13 short-term price targets ranging from a low of $23 to a high of$ 45, with a standard deviation of $6.28. While the lowest estimate indicates a decline of 2.1% from the current price ...